TTE:NYSETotalEnergies SE Analysis
Data as of 2026-08-01 - not real-time
$87.86
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Valuation & Fundamentals: TotalEnergies trades at a trailing P/E of roughly 11, well below the industry average of 22, and its price‑to‑book and price‑to‑sales ratios are comfortably under 2 and 1 respectively. Revenue is growing at nearly 28% YoY, margins are solid (gross ~38%, operating ~13%) and free cash flow exceeds $13 bn, supporting a 4.8% dividend with a payout ratio under 50%, suggesting sustainability.
Technical & Market Sentiment: The stock sits above its 20‑, 50‑ and 200‑day moving averages, RSI is in the 60s and MACD is bullish, indicating short‑term momentum. Volatility is high (≈30% 30‑day) but beta is near zero, limiting market‑wide swings. Analyst consensus is a “Buy” with a median target of $94, implying ~8% upside, while the Fear & Greed Index shows “Extreme Greed,” reflecting strong investor appetite.
Technical & Market Sentiment: The stock sits above its 20‑, 50‑ and 200‑day moving averages, RSI is in the 60s and MACD is bullish, indicating short‑term momentum. Volatility is high (≈30% 30‑day) but beta is near zero, limiting market‑wide swings. Analyst consensus is a “Buy” with a median target of $94, implying ~8% upside, while the Fear & Greed Index shows “Extreme Greed,” reflecting strong investor appetite.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Price just below resistance at $88.6 with bullish MACD
- Strong dividend yield offering immediate income
- Analyst median target providing modest upside
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Robust revenue growth and expanding cash generation
- Undervalued valuation multiples versus peers
- Capital increase aimed at employee ownership, aligning incentives
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Strategic divestments and shift toward low‑carbon assets
- Sustainable dividend supported by free cash flow
- Long‑term energy transition opportunities across integrated segments
Key Metrics & Analysis
Financial Health
Revenue Growth27.80%
Profit Margin9.08%
P/E Ratio10.9
ROE14.48%
ROA5.51%
Debt/Equity48.05
P/B Ratio1.5
Op. Cash Flow$33.0B
Free Cash Flow$13.5B
Industry P/E22.1
Technical Analysis
TrendNeutral
RSI64.1
Support$76.05
Resistance$88.62
MA 20$82.24
MA 50$83.85
MA 200$77.28
MACDBullish
VolumeStable
Fear & Greed Index92.88
Valuation
Fair Value$199.11
Target Price$95.00
Upside/Downside8.13%
GradeUndervalued
TypeBlend
Dividend Yield4.82%
Risk Assessment
Beta-0.16
Volatility30.02%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.